The Diabetes Channel

Comparing GLP-1 Receptor Agonists and DPP-4 Inhibitors for the Treatment of Type 2 Diabetes

Discussions in Diabetes

1:50 | Diabetes, Discussions in Diabetes Microsite

Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C vs DPP-4 inhibitors, though they require injection, which may pose a barrier for some patients.

More in Diabetes

► 06:22

Endocrinology & Metabolism Institute Diabesity Innovations

Diabetes

Bartolome Burguera, MD, PhD, describes the Endocrinology and Metabolism Institute, which is part of Cleveland Clinic. This multidisciplinary institute includes more than 50 medical and surgical endocrine specialists, pituitary specialists,...

► 09:17

Doctor Explains 13 Skin Signs of Diabetes – Never Ignore These Symptoms

Diabetes

This informative video, hosted by Khalid, a family doctor based in London, uncovers 13 skin conditions linked to diabetes, emphasizing the skin's role as a diagnostic window to internal health...

► 37:28

Update: Clinical Practice Guideline on the Management of Hyperglycemia in Hospitalized Patients

Diabetes

At the ENDO 2022 press conference, the clinical practice guideline on management of hyperglycemia in hospitalized patients in non-critical care settings was presented by Mary Korytkowski, MD, University of Pittsburgh,...

► 02:06

Pancreatic Transplants: A Cure for Diabetes?

Diabetes

Tambi Jarmi, MD, nephrologist in the Gary and Dianne McCalla Center for Transplantation and Regenerative Care at Mayo Clinic, discusses the use of early pancreas transplantation to cure diabetes. Because...